Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase NA 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 11Neoplasm, Residual 2Triple Negative Breast Neoplasms 1Recurrence 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Lung Neoplasms 1Leukemia, Myeloid 1Leukemia 1Carcinoma, Non-Small-Cell Lung 1Carcinogenesis 1Breast Neoplasms 1

Interventions

Behavior Therapy 2venetoclax 1Social Determinants of Health 1Cytarabine 1Busulfan 1Blood Specimen Collection 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myeloid × Azacitidine × Clear all
NCT02489929 2015-07-03

Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

Assistance Publique Hopitaux De Marseille

Phase NA Unknown
35 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡